Vieco US has broad licensing rights for certain key operational issues and others for us, including: Includes 30,999,976 shares held by common shares which, 30,999,976 warrants issued and in the process of acquiring the common shares of the filers (including warrants which are the basis of 1,785,687 shares issued and outstanding, each representing one common share and one third of an option). In accordance with Rule 416 of the Securities Act of 1933, as amended, this registration statement is considered to be an unspecated number of additional shares to be offered or issued from fractions of shares, share dividends or similar transactions relating to the shares to be registered. The registration includes up to 105 million outstanding common shares and up to 8 million shares served in the exercise of warrants issued in a private placement, as indicated in a notification to the Securities and Exchange Commission. The filing converts an S-1 return from May to S-3 and does not necessarily indicate that a sale has commenced or will take place in the future. Our Foundation Certificate limits the liability of our directors to the extent permitted by the DGCL and our statutes provide that we will compensate them to the widest possible extent. We have entered into agreements and expect us to continue to enter into agreements to compensate our directors, senior executives and other agents in accordance with the staff defined by our Board of Directors. In accordance with the provisions of these compensation agreements, we must compensate as much as possible each of our directors and officers, who is authorized by Delaware state laws, if the basis for the participation of the compensation is based on the fact that the holder of the exemption is or was or was our director or officer or, at our request , has officially served another organization. We must compensate our executives and directors for any reasonable costs, expenses, expenses and other expenses of any kind and nature, including any expenses and obligations that have been paid or incurred in connection with the investigation, defence, supervision, participation in (including appeal) or preparation of the defence. , testimony or © 2020 Insider Inc. and finanzen.net GmbH (Legal Mentions). All rights reserved.
The information contained in this interim prospectus is not complete and may be changed. These securities can only be sold when the registration statement filed with the Securities and Exchange Commission is effective. This interim prospectus is not an offer to sell or an offer to buy these securities in a country where the offer or sale is not authorized. (3) Remove from registration, by amendment under an amendment, all listed securities that are not sold at the end of the offer. This prospectus is part of a registration statement we filed with the U.S. Securities and Exchange Commission (SEC) using a shelf registration procedure. If applicable, we will add to this prospectus a prospectus containing specific information about the securities offered and sold and the specific terms of this offer. We may also authorize the provision of one or more free prospectuses that may contain essential information about these offers.
The prospectus supplement or free prospectus may also add, update or change information contained in this prospectus regarding this offer. If there is an inconsistency between the information contained in this prospectus and the applicable prospectus supplement or free prospectus, you must rely on the addendum or free prospectus, if any.